Treatment alternatives for anxiety from natural and traditional medicine with Verbesina persicifolia
Keywords:
Anxiety, Medicinal plants, Anxiolytics, Natural MedicineAbstract
Introduction: Anxiety disorders are currently the most prevalent psychiatric disorders worldwide. Natural and traditional medicine can play an important role in obtaining effective treatments with fewer adverse effects than traditional treatments.
Objective: To argue the importance of studying the anxiolytic effects of Verbesina persicifolia as a natural and traditional medicine treatment for anxiety in humans.
Methods: A narrative bibliographic review was carried out, which involved consulting multiple investigations through the Google Scholar search engine in databases such as ScieLo, Redalyc, Pumbed and Scopus. The terms that allowed the search for the referenced and cited information were: anxiety; medicinal plants; anxiolytics; natural medicine. The search strategy consisted of including articles published in English or Spanish and with scientific validity demonstrated from systematic reviews, meta-analyses, quasi-experimental or experimental studies.
Development: anxiety is a public health problem that affects the quality of life of those who suffer from it. The use and consumption of plants for their medicinal properties plays an important role in the search for new active ingredients for the treatment of various ailments that affect health and, together with the applications of nanotechnology for the improvement of biological activity, offer an important alternative for study. Pharmacological studies on Verbesina persicifolia have shown that it has anxiolytic-type effects in animal models of anxiety. Conclusions: it is important to improve and maintain the anxiolytic efficacy of Verbesina persicifolia for anxiety in humans through the use of pharmaceutical technology.
References
1. Martínez-Taboas A. Pandemias, COVID-19 y Salud Mental: ¿Qué Sabemos Actualmente? Rev Cari Psicol [Internet]. 2020 [citado 13 de febrero de 2025]; 4(2):143-52. Disponible en: https://revistacaribenadepsicologia.com/index.php/rcp/article/view/4907
2. Valero Cedeño NJ, Vélez Cuenca MF, Duran Mojica Ányelo A, Torres Portillo M. Afrontamiento del COVID-19: estrés, miedo, ansiedad y depresión. Enferm. investig. [Internet]. 2020 [citado 13 de febrero de 2025]; 5(3):63-70. Disponible en: https://revistas.uta.edu.ec/erevista/index.php/enfi/article/view/913
3. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci [Internet]. 2017 [citado 13 de febrero de 2025]; 19(2):93-107. Disponible en: https://doi.org/10.31887/DCNS.2017.19.2/bbandelow
4. Carballo MM, Estudillo CP, Meraz LL, Parrazal LB, Valle CM. Trastornos de ansiedad: revisión bibliográfica de la perspectiva actual. eNeurobiología [Internet]. 2019 [citado 13 de febrero de 2025]; 10(24). Disponible en: https://doi.org/2.10.25009/eb.v10i24.2544
5. Romero-Cerecero O, Islas-Garduño AL, Tortoriello García J. Uso de plantas medicinales en pacientes con síntomas de ansiedad generalizada. Revista Médica del Instituto Mexicano del Seguro Social [Internet]. 2019 [citado 14 Feb 2025]; 57 (6). Disponible en: http://www.redalyc.org/articulo.oa?id=457764437007
6. Robinson OJ, Pike AC, Cornwell B, Grillon C. Los circuitos neuronales traslacionales de la ansiedad. Diario de la neurología, de la neurocirugía y de la psiquiatría [Internet]. 2019 [citado 13 de febrero de 2025]; 90(12), 1353-1360. Disponible en: https://www.ijpbs.net/archive-issue.php?issueid=10
7. Díaz-Peñaloza M. Las benzodiacepinas y sus efectos sobre la ansiedad. Cultura: Revista de la Asociación de Docentes de la USMP [Internet]. 2017 [citado 13 de febrero de 2025]; 31:(169-180). Disponible en: https://doi.org/10.24265/cultura.2017.v31.09
8. Verdú ES, Caldentey CV, del Río FM, Fraile JS. Criterios de utilización de los medicamentos para tratar la ansiedad aguda y crónica. FMC-Formación Médica Continuada en Atención Primaria [Internet]. 2017 [citado 13 de febrero de 2025]; 24(2). Disponible en: https://10.1016/j.fmc.2016.08.005
9. Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol [Internet]. 2016 [citado 13 de febrero de 2025]; 30(3):198-215. Disponible en: https://doi.org/doi: 10.1111/fcp.12186
10. Goyal S, Kumar S. Anti-anxiety activity studies of various extracts of Pulsatilla nigricans Stoerck. Int J Pharmacol Sci Drug Res [Internet]. 2010 [citado 13 de febrero de 2025]; 2(4):291-3. Disponible en: https://doi.org/10.25004/IJPSDR.2010.020414
11. Herrera-Ruiz M, Jiménez-Ferrer JE, De Lima TC, Avilés-Montes D, Pérez-García D, González-Cortazar M, Tortoriello J. Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca. Phytomedicine [Internet]. 2006 [citado 13 de febrero de 2025]; 13(1-2):23-8. Disponible en: https://doi.org/10.1016/j.phymed.2005.03.003
12. López-Rubalcava C, Estrada-Camarena E. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. J Ethnopharmacol [Internet]. 2016 [citado 13 de febrero de 2025]; 186:377-391. Disponible en: https://doi.org/10.1016/j.jep.2016.03.053
13. Soto-Ojeda GA, Villanueva-Lendechy MA, Saavedra-Vélez MV, Hernández-Lozano M. Evaluación del efecto ansiolítico de la infusión de Verbesina persicifolia en un modelo murino. Rev Ciencias Médicas [Internet]. 2024 [citado 14 Feb 2025]; 28 (1). Disponible en: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6577
14. Global Health Data Exchange. Seattle: Institute for Health Metrics and Evaluation [Internet]. 2019 [citado 13 de febrero de 2025]. Disponible en: https://vizhub.healthdata.org/gbd-results?params=gbd-api-2019-permalink/716f37e05d94046d6a06c1194a8eb0c9
15. Chakraborty A, Amudha P, Geetha M, Surjit-Singh N. Evaluation of anxiolytic activity of methanolic extract of Sapindus mukorossi gaertn in mice. Int J Pharm Biol Sci [Internet]. 2010 [citado 13 de febrero de 2025]; 1(3):1-8. Disponible en: https://www.researchgate.net/publication/286314648
16. Sampath S, Santosh T, Mangala-Lahkar P, Ajaygodwin P, Kumar P, Lingesh A. Anxiolytic effect of ethanolic extract of oxalis corniculata L. in mice. Int J Pharmacol Bio Sci [Internet]. 2011 [citado 13 de febrero de 2025]; 2:(12)281-90. Disponible en: https://www.researchgate.net/publication/286344781_Anxiolytic_effect_of_Ethanolic_extract_of_Oxalis_corniculata_L_in_mice
17. Álvarez-Chimal R, García-Pérez VI, Álvarez-Pérez MA, Arenas-Alatorre JÁ. Green synthesis of ZnO nanoparticles using a Dysphania ambrosioides extract. Structural characterization and antibacterial properties. Mater Sci Eng C Mater Biol Appl [Internet]. 2021 [citado 13 de febrero de 2025]; 118:111540. Disponible en: https://doi.org/10.1016/j.msec.2020.111540
18. Calhoon GG, Tye KM. Resolving the neural circuits of anxiety. Nat Neurosci [Internet]. 2015 [citado 13 de febrero de 2025]; 18(10):1394-404. Disponible en: https://doi.org/10.1038/nn.4101
19. Begum A, Biswas P, Shahed-Al-Mahmud M. Methanol Extract of Spathodea campanulata P (Beauv.) Leaves Demonstrate Sedative and Anxiolytic Like Actions on Swiss Albino Mice. Clinical Phytoscience [Internet]. 2020 [citado 13 de febrero de 2025]; 6, 1-2. Disponible en: https://doi.org/10.1186/s40816-020-00182-z
20. Dalla-Vía LN, García-Argaez A, Braga A, Martínez-Vázquez M, Grancara S, Martinis P Toninello A. An eudesman derivative from Verbesina persicifolia DC as a natural mild uncoupler in liver mitochondria. A new potential anti-obesity agent? Current pharmaceutical design [Internet]. 2014 [citado 14 Feb 2025]; 20(2), 253-261. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23701541/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gabriel Arturo Soto Ojeda, Juan Pablo Martínez Castillo, Mauro Antonio Villanueva Lendechy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain copyright and all unrestricted publication rights.
Medicoquirúrgicas Research is licensed under the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0) and follows the SciELO Publishing Schema (SciELO PS) for publishing in XML format.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material.
The license cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do this in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Non-Commercial — You may not use the material for commercial purposes.
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from making any use permitted by the license.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where their use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all the permissions you need for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
